ZENTALIS PHARMACEUTICALS, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • March 30th, 2020 • Zentalis Pharmaceuticals, LLC • Pharmaceutical preparations • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of , 20[20] between Zentalis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and [Name] (“Indemnitee”).
●] Shares ZENTALIS PHARMACEUTICALS, INC. COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • March 30th, 2020 • Zentalis Pharmaceuticals, LLC • Pharmaceutical preparations • New York
EMPLOYMENT AGREEMENTEmployment Agreement • March 30th, 2020 • Zentalis Pharmaceuticals, LLC • Pharmaceutical preparations • New York
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into by and between Zeno Management, Inc., a Delaware corporation (the “Company”) and a wholly owned subsidiary of Zentalis Pharmaceuticals, LLC (the “Parent”), and Dimitris Voliotis, M.D. (“Executive”), and shall be effective as of March 25, 2020 (the “Effective Date”).
ZENTALIS PHARMACEUTICALS, INC. RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • March 30th, 2020 • Zentalis Pharmaceuticals, LLC • Pharmaceutical preparations • Delaware
These instructions are provided to assist you if you choose to make an election under Section 83(b) of the Internal Revenue Code, as amended, with respect to the shares of common stock of Zentalis Pharmaceuticals, Inc. transferred to you. Please consult with your personal tax advisor as to whether an election of this nature will be in your best interests in light of your personal tax situation.
